Twist Bioscience Corp (NASDAQ:TWST) — Market Cap & Net Worth
Market Cap & Net Worth: Twist Bioscience Corp (TWST)
Twist Bioscience Corp (NASDAQ:TWST) has a market capitalization of $4.31 Billion ($4.31 Billion) as of August 7, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #3938 globally and #1365 in its home market, demonstrating a 29.88% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Twist Bioscience Corp's stock price $115.01 by its total outstanding shares 62271314 (62.27 Million). Review how much debt does Twist Bioscience Corp carry to assess the company's total debt and financial obligations.
Twist Bioscience Corp Market Cap History: 2018 to 2026
Twist Bioscience Corp's market capitalization history from 2018 to 2026. Data shows growth from $1.44 Billion to $7.16 Billion (31.15% CAGR).
Index Memberships
Twist Bioscience Corp is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.48 Trillion | 0.17% | #92 of 976 |
|
NASDAQ Composite
IXIC
|
$40.85 Trillion | 0.01% | #452 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.73 Trillion | 0.25% | #61 of 263 |
Weight: Twist Bioscience Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Twist Bioscience Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Twist Bioscience Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.25x
Twist Bioscience Corp's market cap is 5.25 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $1.44 Billion | $25.43 Million | -$71.24 Million | 56.55x | N/A |
| 2019 | $1.31 Billion | $54.38 Million | -$107.67 Million | 24.05x | N/A |
| 2020 | $8.80 Billion | $90.10 Million | -$139.93 Million | 97.65x | N/A |
| 2021 | $4.82 Billion | $132.33 Million | -$152.10 Million | 36.42x | N/A |
| 2022 | $1.48 Billion | $203.56 Million | -$217.86 Million | 7.28x | N/A |
| 2023 | $2.30 Billion | $245.11 Million | -$204.62 Million | 9.36x | N/A |
| 2024 | $2.89 Billion | $312.97 Million | -$208.73 Million | 9.25x | N/A |
| 2025 | $1.98 Billion | $376.57 Million | -$77.67 Million | 5.25x | N/A |
Competitor Companies of TWST by Market Capitalization
Companies near Twist Bioscience Corp in the global market cap rankings as of August 7, 2026.
Key companies related to Twist Bioscience Corp by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $217.10 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #165 globally with a market cap of $141.03 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #498 globally with a market cap of $53.38 Billion USD ( CN¥364.81 Billion CNY).
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #622 globally with a market cap of $43.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $217.10 Billion | $577.83 |
| #165 | Danaher Corporation | NYSE:DHR | $141.03 Billion | $199.66 |
| #498 | WuXi AppTec Co Ltd | SHG:603259 | $53.38 Billion | CN¥147.50 |
| #622 | IDEXX Laboratories Inc | NASDAQ:IDXX | $43.83 Billion | $584.78 |
Twist Bioscience Corp Historical Marketcap From 2018 to 2026
Between 2018 and today, Twist Bioscience Corp's market cap moved from $1.44 Billion to $ 7.16 Billion, with a yearly change of 31.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $7.16 Billion | +262.58% |
| 2025 | $1.98 Billion | -31.74% |
| 2024 | $2.89 Billion | +26.07% |
| 2023 | $2.30 Billion | +54.81% |
| 2022 | $1.48 Billion | -69.23% |
| 2021 | $4.82 Billion | -45.23% |
| 2020 | $8.80 Billion | +572.81% |
| 2019 | $1.31 Billion | -9.05% |
| 2018 | $1.44 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 6th, 2026 the market cap of Twist Bioscience Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.31 Billion USD |
| MoneyControl | $4.31 Billion USD |
| MarketWatch | $4.31 Billion USD |
| marketcap.company | $4.31 Billion USD |
| Reuters | $4.31 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Twist Bioscience Corp
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo … Read more